Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 284.59MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
Sector
Industry
History
$ 15.19Close
$ 9.55 - $ 70 52-Week Range
Ticker Information
Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKEROS THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KROS - CF - Chg. Cash Historical data
| Date | Net Cash Flow - Change in Cash & Cash Equivalents |
|---|---|
| 6/30/2025 | $ 284.59M |
| 3/31/2025 | $ 278.33M |
| 12/31/2024 | $ 229.02M |
| 9/30/2024 | $ 243.03M |
| 6/30/2024 | $ 83.72M |
| 3/31/2024 | $ 90.9M |
| 12/31/2023 | $ 51.98M |
| 9/30/2023 | $ 48.35M |
| 6/30/2023 | $ 106.41M |
| 3/31/2023 | $ 122.84M |
Key Performance Insights, Last 5 Years
- KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 258.86M.
- Over the past 5 years, KEROS THERAPEUTICS INC's average CF - Chg. Cash has been $ 114.04M.
- The median CF - Chg. Cash for KEROS THERAPEUTICS INC during this period was $ 90.9M
- KEROS THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 284.59M.
- The lowest CF - Chg. Cash recorded by KEROS THERAPEUTICS INC in the same timeframe $ -34.62M
KEROS THERAPEUTICS INC's CF - Chg. Cash vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Chg. Cash Benchmarks
Similar metrics to CF - Chg. Cash:
- Net Cash Flow - Exchange Rate Changes on Cash - [Cash Flow Statement] Refers to the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Net Cash Flow - Investing - [Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
Definition of Net Cash Flow - Change in Cash & Cash Equivalents
[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]KROS - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years
$ -34.62M
Minimum
Dec 31, 2021
$ 284.59M
Maximum
Jun 30, 2025
$ 114.04M
Average
$ 90.9M
Median
CF - Chg. Cash Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.14M with a standard deviation of $ 44.86M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
| filtered constituents | 3.34K |
|---|---|
| min | $ -136.09M |
| max | $ 136.7M |
| average | $ 1.14M |
| median | $ 115.89K |
| std | $ 44.86M |